» Articles » PMID: 34179085

Varied Contribution of Phospholipid Shedding From Membrane to Daptomycin Tolerance in

Overview
Specialty Biology
Date 2021 Jun 28
PMID 34179085
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

It has been suggested that daptomycin can be inactivated by lipids released by and that this effect is antagonized by phenol soluble modulins (PSMs), which bind to the shed lipids. PSM production is regulated by the Agr system, and others have shown that loss of the Agr function enhances survival in the presence of daptomycin. Here we assessed the impact of Agr function on daptomycin activity and lipid metabolism under various conditions. Daptomycin activity was evaluated against three sets of isogenic strain series with wild-type or dysfunctional Agr using static daptomycin time-kills over 24 h and against one strain pair using pharmacokinetic/pharmacodynamic (PK/PD) models simulating clinical daptomycin exposure for 48 h. We performed comprehensive lipidomics on bacterial membranes and the spent media to correlate lipid shedding with survival. In static time-kill experiments, two -deficient strains (SH1000- and USA300 LAC Δ) showed improved survival for 8 h compared with their corresponding wild-type strains as seen in previous studies, but this difference did not persist for 24 h. However, four other -deficient strains (SH1001 and JE2 KOs) did not demonstrate improved survival compared to isogenic wild-type strains at any time in the time-kills. Lipidomics analysis of SH1000, SH1001, and SH1000- strains showed daptomycin exposure increased lipid shedding compared to growth controls in all strains with phosphatidylglycerols (PGs), lysylPGs and cardiolipins predominating. In the cell pellets, PGs and lysylPGs decreased but cardiolipins were unchanged with daptomycin exposure. The shed lipid profiles in SH1001 and SH1000- were similar, suggesting that the inability to resist daptomycin by SH1001 was not because of differences in lipid shedding. In the PK/PD model, the mutant SH1000- strain did not show improved survival relative to SH1000 either. In conclusion, inactivation of daptomycin by shed lipids may be dependent on genetic background, the specific mutations, or the techniques used to generate these KOs rather than the overall function of the Agr system, and its contribution to daptomycin tolerance seems to be varied, transient, and growth-condition dependent.

Citing Articles

Molecular phenotyping approaches for the detection and monitoring of carbapenem-resistant Enterobacteriaceae by mass spectrometry.

Dixon B, Ahmed W, Felton T, Fowler S J Mass Spectrom Adv Clin Lab. 2022; 26:9-19.

PMID: 36105942 PMC: 9464899. DOI: 10.1016/j.jmsacl.2022.09.001.


Proteome profiling of evolved methicillin-resistant strains with distinct daptomycin tolerance and resistance phenotypes.

Sulaiman J, Long L, Qian P, Lam H Front Microbiol. 2022; 13:970146.

PMID: 35992709 PMC: 9386379. DOI: 10.3389/fmicb.2022.970146.


Polymyxin and lipopeptide antibiotics: membrane-targeting drugs of last resort.

Ledger E, Sabnis A, Edwards A Microbiology (Reading). 2022; 168(2).

PMID: 35118938 PMC: 8941995. DOI: 10.1099/mic.0.001136.

References
1.
Mishra N, Bayer A . Correlation of cell membrane lipid profiles with daptomycin resistance in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2012; 57(2):1082-5. PMC: 3553710. DOI: 10.1128/AAC.02182-12. View

2.
Mehta S, Cuirolo A, Plata K, Riosa S, Silverman J, Rubio A . VraSR two-component regulatory system contributes to mprF-mediated decreased susceptibility to daptomycin in in vivo-selected clinical strains of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2011; 56(1):92-102. PMC: 3256076. DOI: 10.1128/AAC.00432-10. View

3.
Sakoulas G, Eliopoulos G, Moellering Jr R, Wennersten C, Venkataraman L, Novick R . Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin. Antimicrob Agents Chemother. 2002; 46(5):1492-502. PMC: 127153. DOI: 10.1128/AAC.46.5.1492-1502.2002. View

4.
Pader V, Hakim S, Painter K, Wigneshweraraj S, Clarke T, Edwards A . Staphylococcus aureus inactivates daptomycin by releasing membrane phospholipids. Nat Microbiol. 2016; 2:16194. DOI: 10.1038/nmicrobiol.2016.194. View

5.
Mishra N, Yang S, Chen L, Muller C, Saleh-Mghir A, Kuhn S . Emergence of daptomycin resistance in daptomycin-naïve rabbits with methicillin-resistant Staphylococcus aureus prosthetic joint infection is associated with resistance to host defense cationic peptides and mprF polymorphisms. PLoS One. 2013; 8(8):e71151. PMC: 3747195. DOI: 10.1371/journal.pone.0071151. View